850996-94-0

Basic information

• Product Name: 3-Oxazolidinecarboxylic acid, 2,2-dimethyl-4-[(2S)-3-[[(phenylmethoxy)carbonyl]amino]-2-[[tris(1-meth ylethyl)silyl]oxy]propyl]-, 1,1-dimethylethyl ester, (4S)-
• CAS NO: 850996-94-0
• Molecular Formula: C30H52N2O6Si
• Molecular Weight: 564.838
• Mol File: 850996-94-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-Oxazolidinecarboxylic acid, 2,2-dimethyl-4-[(2S)-3-[[(phenylmethoxy)carbonyl]amino]-2-[[tris(1-meth ylethyl)silyl]oxy]propyl]-, 1,1-dimethylethyl ester, (4S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Oxazolidinecarboxylic acid, 2,2-dimethyl-4-[(2S)-3-[[(phenylmethoxy)carbonyl]amino]-2-[[tris(1-meth ylethyl)silyl]oxy]propyl]-, 1,1-dimethylethyl ester, (4S)-(850996-94-0)
• EPA Substance Registry System: 3-Oxazolidinecarboxylic acid, 2,2-dimethyl-4-[(2S)-3-[[(phenylmethoxy)carbonyl]amino]-2-[[tris(1-meth ylethyl)silyl]oxy]propyl]-, 1,1-dimethylethyl ester, (4S)-(850996-94-0)

Safety Data

• Hazardous Substances Data: 850996-94-0(Hazardous Substances Data)

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 147959-19-1 (4S)-2,2-dimethyl-3-(t-butoxycarbonyl)-4-(formylmethyl)-1,3-oxazolidine 
• 147959-18-0 (4S)-2,2-dimethyl-4-(2-hydroxyethyl)oxazolidine-3-carboxylic acid tert-butyl ester 
• 128427-09-8 (S)-N-tert-butoxycarbonyl-aspartic acid diethyl ester 
• 128427-10-1 (S)-2-(tert-butoxycarbonylamino)-1,4-butanediol 
• 80522-42-5 triisopropylsilyl trifluoromethanesulfonate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 850996-87-1 (4S)-4-[2-(1-methoxy-1-methylethoxy)ethyl]-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 

Downstream Products

• 850996-95-1 (2S,4S)-1-hydroxy-4-triisopropylsilanyloxy-5-benzyloxycarbonylaminopent-2-ylaminocarboxylic acid tert-butyl ester 

Relevant articles and documents

Highly efficient approach to orthogonally protected (2S,4R)- and (2S,4S)-4-hydroxyornithine

(Chemical Equation Presented) A concise stereoselective approach to both orthogonally protected (25,4A)- and (2S,4S)-4-hydroxyornithine, key constituents of the biphenomycin-and clavalanine-type antibiotics, respectively, has been developed. The approach is based on bis(oxazoline) copper(II)-complex-catalyzed diastereoselective Henry reactions of nitromethane with the homoserine-derived aldehyde 6. The synthesis of this versatile chiral building block has been markedly improved.